[1] Ferlay J, Soerjomataram I, Dikshit R, et al. Int J Cancer, 2015, 136(5):E359 [2] Tamura K, Fukuoka M. EOP, 2005, 6(6):985 [3] Martens U M. Small Molecules in Oncology. 3rd ed. Cham:Springer International Publishing AG, 2018:235 [4] Fang L, Song Y, Weng X, et al. BMC, 2015, 29(12):1937 [5] Lemmon M A, Schlessinger J. Cell, 2010, 141(7):1117 [6] Li M D, Zheng Y G, Ji M. Molecules, 2007, 12(3):673 [7] Guan Z Z, Zhang L, Li L Y, et al. CJC, 2005, 24(8):980 [8] Li J K, Wang S S, Chen X F, et al. Life Science Instrument, 2017, 1:50 [9] Yang Q Y, Xu G C, Chen L K. Chinese Journal of Neurological Oncology, 2004, 3:197 [10] Wang S S, Ning F S, Li X L, et al. JPA, 2017, 37:1309 [11] Wu X H, Luo A, Ye L B, et al. Journal of Instrumental Analysis, 2016, 35(1):35 [12] Bouder F. Expert Rev Clin Pharmacol, 2008, 1(2):241 [13] Mueller L, Mauthe R J, Riley C M, et al. Regul Toxicol Pharmacol, 2006, 44(3):1 [14] European Medicines Agency Evaluation of Medicines for Human Use (EMEA). Committee for Medicinal Products for Human Use time (CHMP) Guidelines on the Limits of Genotoxic Impurities (CPMP/SWP/5199/02). (2006-06-28)[2019-06-28]. https://wenku.baidu.com/view/df144e93caaedd3382c4d381.html?rec_flag=default&sxts=1570875771345 [15] Liu X W, Li C, Han Y H, et al. Chinese Journal of Chromatography, 2018, 36(10):952 [16] U S Food and Drug Administration. Department of Health and Human Services, Center for Drug Evaluation and Research (CDER) Guidance for industry. Genotoxic and Carcinogenic Impurities in Drug Substances and Products:Recommended Approaches (Draft).[2019-06-28]. https://wenku.baidu.com/view/96773cecb8f67c1cfad6b8a5.html [17] China Food and Drug Administration. Pharmacopoeia of the People's Republic of China. (2015-06-05)[2019-06-28]. http://db.ouryao.com/yd2015 [18] ICH.M7 Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk. (2014-06-23)[2019-06-28]. http://db.ouryao.com/ich/list.php?id=51 [19] Xie W F, Gao Y Z, Tang X X. JPA, 2018, 38(12):2110 [20] Yuan Q Y, Li C, Li J C, et al. Chinese Journal of Modern Applied Pharmacy, 2017, 34(3):407 [21] Xu J. JPA, 2017, 37(1):105 [22] Luan B L, Xu X J, Liang G T, et al. Journal of China Pharmaceutical University, 2019, 50(3):325 [23] Hou J F, Li M, Qi L, et al. China Medical Herald, 2018, 15(3):126 |